본문으로 건너뛰기
← 뒤로

Extent of Surgical Resection and Predictors of Outcomes in MEN1-related Hyperparathyroidism: A Systematic Review and Meta-analysis.

The Journal of clinical endocrinology and metabolism 2025 Vol.111(1) p. 291-301

Alves Filho W, Filho FJFP, Morais VMC, Gonçalves VB, Brescia MDG, Montenegro FLM, d'Alva CB, Quidute ARP, Studart da Fonseca MR

📝 환자 설명용 한 줄

[CONTEXT] Primary hyperparathyroidism (PHPT) is the earliest and most frequent manifestation of multiple endocrine neoplasia type 1 (MEN1).

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • 95% CI 1.16-1.36
  • RR 1.26
  • 연구 설계 systematic review

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Alves Filho W, Filho FJFP, et al. (2025). Extent of Surgical Resection and Predictors of Outcomes in MEN1-related Hyperparathyroidism: A Systematic Review and Meta-analysis.. The Journal of clinical endocrinology and metabolism, 111(1), 291-301. https://doi.org/10.1210/clinem/dgaf492
MLA Alves Filho W, et al.. "Extent of Surgical Resection and Predictors of Outcomes in MEN1-related Hyperparathyroidism: A Systematic Review and Meta-analysis.." The Journal of clinical endocrinology and metabolism, vol. 111, no. 1, 2025, pp. 291-301.
PMID 40891326

Abstract

[CONTEXT] Primary hyperparathyroidism (PHPT) is the earliest and most frequent manifestation of multiple endocrine neoplasia type 1 (MEN1). The optimal surgical extent remains controversial due to the tradeoff between recurrence and permanent hypoparathyroidism.

[OBJECTIVE] To evaluate outcomes of different surgical approaches in MEN1-related PHPT and assess preoperative biochemical predictors through systematic review and meta-analysis.

[DATA SOURCES] MEDLINE, PubMed, Embase.com, LILACS, and CENTRAL were searched from inception to April 2025, following PRISMA guidelines (PROSPERO: CRD420251027970).

[STUDY SELECTION] We included studies on adult MEN1-related PHPT patients undergoing parathyroidectomy with reported recurrence, hypoparathyroidism, and preoperative biochemical data.

[DATA EXTRACTION] Two reviewers independently extracted data and assessed study quality. Random-effects models were used to pool risk ratios (RR) with 95% confidence intervals (CI). Meta-regression evaluated associations with preoperative PTH, calcium, and phosphorus.

[DATA SYNTHESIS] Thirteen studies (915 patients) were included. Less-than-subtotal parathyroidectomy (<STPT) had higher recurrence than subtotal parathyroidectomy (STPT) (RR = 1.26; 95% CI: 1.16-1.36) and total parathyroidectomy with autotransplantation (PTX) (RR = 1.35; 95% CI: 1.22-1.49). STPT showed slightly higher recurrence than PTX (RR = 1.12; 95% CI: 1.02-1.24). <STPT had lower hypoparathyroidism than STPT (RR = 0.90; 95% CI: 0.82-0.98) and PTX (RR = 0.76; 95% CI: 0.63-0.90). Grouping < STPT vs STPT/PTX confirmed higher recurrence (RR = 1.23; 95% CI: 1.03-1.46) and lower hypoparathyroidism (RR = 0.86; 95% CI: 0.78-0.96). No significant associations were found for preoperative PTH, calcium, or phosphorus with outcomes.

[CONCLUSION] Conservative surgery reduces hypoparathyroidism but increases recurrence. Personalized surgical strategies are essential in MEN1-related PHPT.

MeSH Terms

Humans; Parathyroidectomy; Multiple Endocrine Neoplasia Type 1; Hyperparathyroidism, Primary; Treatment Outcome; Hypoparathyroidism; Parathyroid Hormone; Prognosis; Recurrence